Literature DB >> 21387464

CGEN--a Clinical GENetics software application.

Pål Møller1, Neal Clark.   

Abstract

CGEN (Clinical GENetics) is a software application built to manage the IT requirements of genetic clinics with the specific focus to collect well-organized and verified data for genetic research. This article describes the functionality of CGEN, the IT requirements for CGEN, and the unique position that CGEN has for clinics who may wish to collaborate data exchange with other clinics or central repositories of genetic data. CGEN was also represented at The Human Variome Project in Paris, 2010, and is a candidate for data collection for this project.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21387464     DOI: 10.1002/humu.21452

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  3 in total

1.  The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation.

Authors:  Pål Møller; Astrid Stormorken; Marit Muri Holmen; Anne Irene Hagen; Anita Vabø; Lovise Mæhle
Journal:  Breast Cancer Res Treat       Date:  2014-03-12       Impact factor: 4.872

2.  Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.

Authors:  Pål Møller; Toni Seppälä; Inge Bernstein; Elke Holinski-Feder; Paola Sala; D Gareth Evans; Annika Lindblom; Finlay Macrae; Ignacio Blanco; Rolf Sijmons; Jacqueline Jeffries; Hans Vasen; John Burn; Sigve Nakken; Eivind Hovig; Einar Andreas Rødland; Kukatharmini Tharmaratnam; Wouter H de Vos Tot Nederveen Cappel; James Hill; Juul Wijnen; Kate Green; Fiona Lalloo; Lone Sunde; Miriam Mints; Lucio Bertario; Marta Pineda; Matilde Navarro; Monika Morak; Laura Renkonen-Sinisalo; Ian M Frayling; John-Paul Plazzer; Kirsi Pylvanainen; Julian R Sampson; Gabriel Capella; Jukka-Pekka Mecklin; Gabriela Möslein
Journal:  Gut       Date:  2015-12-09       Impact factor: 23.059

3.  The BRCA2 variant c.68-7 T>A is associated with breast cancer.

Authors:  Pål Møller; Eivind Hovig
Journal:  Hered Cancer Clin Pract       Date:  2017-11-13       Impact factor: 2.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.